SCHEMBL5213205

SCHEMBL5213205

COc1ccc2c(c1)c(OCCO)c(C(=O)O)n2Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 2/20 0.66
CCR2 P41597 9/20 0.62
EDNRB P24530 3/20 0.50
EDNRA P25101 2/20 0.50
PLA2G2A P14555 2/20 0.48
MEN1 O00255 1/20 0.46
RGS12 O14924 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
PKM P14618 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP2C19 P33261 1/20 0.46
GNAI1 P63096 1/20 0.46
PMP22 Q01453 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5212313 0.90 ABCB11 (0.62) ABCB11CCR2EDNRBEDNRAPLA2G2A
SCHEMBL5216231 0.89 ABCB11 (0.52) ABCB11CCR2PLA2G2AMEN1RGS12
SCHEMBL5214261 0.81 ABCB11 (0.51) ABCB11CCR2PLA2G2AMEN1RGS12
SCHEMBL6599243 0.79 ABCB11 (1.00) ABCB11CCR2ALDH1A1MAPTPKM
SCHEMBL6302418 0.76 ABCB11 (0.55) ABCB11CCR2EDNRBEDNRAPLA2G2A
SCHEMBL6302422 0.76 ABCB11 (0.55) ABCB11CCR2EDNRBEDNRAPLA2G2A
SCHEMBL7076664 0.75 ABCB11 (0.53) ABCB11CCR2EDNRBEDNRAPLA2G2A
SCHEMBL7076665 0.75 ABCB11 (0.53) ABCB11CCR2EDNRBEDNRAPLA2G2A
SCHEMBL21465478 0.73 CCR2 (0.64) ABCB11CCR2MEN1ALDH1A1LMNA
SCHEMBL21465499 0.73 ABCB11 (0.58) ABCB11CCR2MEN1RGS12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173421-B1 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2007-10-03 EP disclosed
US-6833387-B1 3-substituted indoles; inhibition of monocyte chemoattractant protein-1 and/or RANTES induced chemotaxis; inflammatory diseases ASTRAZENECA AB (SE) 2004-12-21 US disclosed
EP-1173421-A2 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS AstraZeneca AB (SE) 2002-01-23 EP disclosed
WO-2000046199-A2 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2000-08-10 WO disclosed